The Drug Enforcement Agency (DEA) has proposed a rule change that would limit the telemedicine prescribing of controlled substances when the physician and patient do not have an existing relationship. While this rule is largely aimed at reducing the potential of abuse for opioids in today’s era of overdoses, addiction, and trafficking, it will also have the effect of prohibiting assisted suicide drugs from being provided to a patient via telemedicine.
The assisted-suicide lobby took advantage of the pandemic to increase access to assisted suicide in several ways. While this is not a complete solution, it is an opportunity to provide some additional safeguards.
The proposed rule will have a comment period through March 31, 2023, and public comments make a difference. Hundreds of pro-death lobby individuals have commented on the proposed rule change in opposition to the changes. If you would like to learn more about or comment in support of the rule change, you can do so here. We are providing suggested language below that you can use (or write your own) if you would like to comment in support of this proposed change.
As a quick reminder – anything you post as a comment to a rule becomes public information. Please keep this in mind when commenting – do not include private information and remain professional and respectful.
https://www.federalregister.gov/documents/2023/03/01/2023-04248/telemedicine-prescribing-of-controlled-substances-when-the-practitioner-and-the-patient-have-not-had#open-comment
I support the Drug Enforcement Agency (DEA) in its proposed rule change that will prevent doctors from prescribing Schedule II controlled substances via telehealth when there is no pre-existing doctor/patient relationship.
This proposed rule change is an important step that will assure that controlled substances are not being inappropriately prescribed.
Telemedicine can remove some of the important checks and balances that help to prevent the abuse and misuse of powerful and potentially deadly drugs in this era of opioid addiction, overdose, and trafficking.
The DEA is right to make this rule change.
The assisted-suicide lobby took advantage of the pandemic to increase access to assisted suicide in several ways. While this is not a complete solution, it is an opportunity to provide some additional safeguards.
The proposed rule will have a comment period through March 31, 2023, and public comments make a difference. Hundreds of pro-death lobby individuals have commented on the proposed rule change in opposition to the changes. If you would like to learn more about or comment in support of the rule change, you can do so here. We are providing suggested language below that you can use (or write your own) if you would like to comment in support of this proposed change.
As a quick reminder – anything you post as a comment to a rule becomes public information. Please keep this in mind when commenting – do not include private information and remain professional and respectful.
https://www.federalregister.gov/documents/2023/03/01/2023-04248/telemedicine-prescribing-of-controlled-substances-when-the-practitioner-and-the-patient-have-not-had#open-comment
I support the Drug Enforcement Agency (DEA) in its proposed rule change that will prevent doctors from prescribing Schedule II controlled substances via telehealth when there is no pre-existing doctor/patient relationship.
This proposed rule change is an important step that will assure that controlled substances are not being inappropriately prescribed.
Telemedicine can remove some of the important checks and balances that help to prevent the abuse and misuse of powerful and potentially deadly drugs in this era of opioid addiction, overdose, and trafficking.
The DEA is right to make this rule change.
RSS Feed
